IPO Action Next Week: Glenmark Life Sciences IPO issue details, Tatva Chintan Pharma Chem Ltd IPO allotment updates—All INVESTORS need to know
While Tatva Chintan Pharma Chem Ltd IPO has closed its issue with massive over 180 times subscription on July 20, Glenmark Life Sciences IPO initial public offer will go live on July 27, 2021, and will end on July 29, 2021.
This entire month has been packed with IPO action. From Zomato IPO to GR Infraprojects and Clean Science and Technologyinitial public offerings, the lucky subscribers of these issue have minted huge money this month from listing gains. While Clean Science got listed around 90 per cent above its issue price to Rs 1711 per share on NSE, GR Infra shares clocked over 100 per cent on both BSE and NSE to 1710.15 per share and 1702.05 per share respectively. Similarly, investors of Zomato IPO also made more than 50 % of the issue price as listing gains.
See Zee Business Live TV Streaming Below:
Well, though these companies have been listed on stock exchanges, there are actions due in Tatva Chintan Pharma Chem Ltd IPO and Glenmark Life Sciences IPO. While the former has closed its issue with massive over 180 times subscription on July 20, the later's initial public offer will go live on July 27, 2021, and will end on July 29, 2021.
Here is all you need to know about Glenmark Life Sciences IPO and Tatva Chintan Pharma Chem Ltd IPO allotment date and other details
Glenmark Life Sciences IPO Key Details
Glenmark Life Sciences IPO is opening for public subscription on July 27, 2021 and will concluded on July 29, 2021.
Glenmark Life Sciences may finalise the IPO share allotment on August 4 and the funds will be refunded on August 5, 2021.
Glenmark Life Sciences shares will get credited in demat accounts around August 6.
Glenmark Life Sciences will be listed on exchanges, BSE and NSE, on August 9.
Glenmark Life Sciences is coming up with initial public offerings to raise funds through fresh issue of equity shares aggregating up to Rs 1,060 crore and Offer for Sale up to 63,00,000 equity shares by Glenmark Pharmaceuticals. The face value of equity shares is Rs 2 each.
Kotak Mahindra Capital Company, BofA Securities India, and Goldman Sachs (India) Securities Private are the global co-ordinators and book running lead managers to the issue. DAM Capital Advisors (Formerly known as IDFC Securities), BOB Capital Markets and SBI Capital Markets are the book running lead managers to the issue.
Tatva Chintan Pharma Chem Ltd Important Dates and Allotment Online Check Guide
Finalisation of basis of allotment likely on July 27 as per Edelweiss, while Zerodha puts the date on July 26.
Initiation of refunds likely on 28 July as per Edelweiss, while Zerodha puts it on July 27
Transfer of IPO shares to demat accounts likely on July 29 as per Edelweiss, while according to Zerodha it is July 28.
IPO Listing date as per Edelweiss is July 30, while Zerodha says July 29
Tatva Chintan Pharma Chem Ltd IPO Allotment Check on BSE
Step 1: Visit the link: bseindia.com/investors/appli_check.aspx on BSE official website.
Step 2: In the dropdown menu select 'Equity' for issue type
Step 3: Now, select the name of the IPO, which is Tatva Chintan Pharma Chem Ltd' in this case
Step 4: Here, you will be asked to verify application number & PAN number
Step 5: Hit search button and you are good to go. You can see your IPO allotment on the screen
Steps to check Tatva Chintan Pharma Chem Ltd Allotment on Link Intime:
Step 1: Visit Link Intime India Private Limited IPO allotment link: ris.Linkintime.com/ipostatus/
Step 2: Again, select IPO Name- Tatva Chintan Pharma Chem Ltd '
Step 3: Here, fill in details such as PAN number, application number or DP ID
Step 4: Now, click on 'Search' Button. You can now see your IPO Allotment on the screen.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
06:22 PM IST